Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

TDP-43 Proteinopathies trial results

NCT03489200

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Universidad Católica de Valencia San Vicente Màrtir Valencia, Spain
Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Phoenix Neurological Institute Phoenix, Arizona, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • University Of Kansas Medical Center Kansas City, Kansas, United States
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Inflammation, +11 more
Locations
  • St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Irvine, Department of Neurology Orange, California, United States
View all 22 locations
Conditions
Behavioral Variant Frontotemporal Dementia (bvFTD), Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • David Geffen School of Medicine at UCLA, UCLA Neurological Services Los Angeles, California, United States
  • The Shankle Clinic Newport Beach, California, United States
  • Memory and Aging Centre San Francisco, California, United States
  • Meridien Research Brooksville, Florida, United States
View all 67 locations